Welcome Entering Graduate Student Class of 2026!
The Department of Pharmacology and Cancer Biology is excited to introduce the Class of 2026.Molecular Cancer Biology (MCB)
Pendergast Lab: Two-drug combination may be key to killing deadly small cell lung cancer
Researchers led by Ann Marie Pendergast, PhD, have identified a promising new strategy to fight small cell lung cancer: combining low doses of two cancer drugs to overwhelm tumors that have spread throughout the body.
MCB trainees compete in 3MT competition; Towne wins 2nd place
Ten trainees from across the Graduate School were selected to present at the 3-Minute Thesis
New Funding Awards - April 2026 to June 2026
Congratulations to the following faculty members for receiving these sponsored research awards:
Tsvetanova Promoted to Associate Professor with Tenure
Nina Tsvetanova, PhD, has been promoted to Associate Professor with tenure, effective July 1, 2026.
Klemm Awarded Jane Coffin Childs Memorial Fund for Medical Research Postdoctoral Fellowship
Jake Klemm, PhD, a postdoctoral associate in the lab of Donald Fox, PhD, has been awarded a three-year postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research (JCC Fund).
Team led by Andrew West joins global network to unravel the complexity of Parkinson’s disease
A research team led by Andrew West, PhD, professor of pharmacology and cancer biology at Duke, has been selected to join the Collaborative Research Network, an international, multidisciplinary, multi-institutional network working to address high-priority research questions about Parkinson's disease, through a $9 million grant awarded by Aligning Science Across Parkinson’s (ASAP), in partnership with The Michael J. Fox Foundation for Parkinson’s Research.